2016-05-01
A polymorphism in leuS confers reduced susceptibility to GSK2251052 in a clinical isolate of Staphylococcus aureus
Publication
Publication
Antimicrobial Agents and Chemotherapy , Volume 60 - Issue 5 p. 3219- 3221
Copyright
Additional Metadata | |
---|---|
doi.org/10.1128/AAC.02940-15, hdl.handle.net/1765/90780 | |
Antimicrobial Agents and Chemotherapy | |
Organisation | Erasmus MC: University Medical Center Rotterdam |
Gupta, A., Monteferrante, C., Rasina, D., Leitis, G., Randall, C. P., Tomlinson, J. H., … O'Neill, A. J. (2016). A polymorphism in leuS confers reduced susceptibility to GSK2251052 in a clinical isolate of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy, 60(5), 3219–3221. doi:10.1128/AAC.02940-15 |